Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

格华止 - NMPA Drug Approval Details

Approvals/NMPA/Metformin Hydrochloride Tablets

Approved

化学药品

Metformin Hydrochloride Tablets

默克制药（江苏）有限公司🇨🇳 National Medical Products Administration

Approval Date: Jan 10, 2020
Approval ID: 7LeaeHQlKll
Company: 默克制药（江苏）有限公司
Type: 化学药品

Approval Details

Approval Id: 7LeaeHQlKll
Approval Number: 国药准字H20023370
Generic Name: 盐酸二甲双胍片
Generic Name En: Metformin Hydrochloride Tablets
Trade Name: 格华止
Brand Name: 格华止
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 0.5g
Reg Date: 2020-01-10
Company Name: 默克制药（江苏）有限公司
Company Address: 江苏省南通经济技术开发区和兴路168号
Production Company Name: 中美上海施贵宝制药有限公司;山东新华制药股份有限公司
Production Company Address: 上海市闵行剑川路1315号；山东省淄博市高新区鲁泰大道1号
Company Detail Path: /organization/mo-ke-zhi-yao-jiang-su-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jan 10, 2020

Approval ID

7LeaeHQlKll

Type

化学药品

Back to NMPA Approvals